Bildkälla: Stockfoto

Genovis Q3 2024: Beat across the board - Redeye

Redeye provides an updated view on Genovis following a Q3 report that surpassed our estimates across the board. We have made slight adjustments to our model and largely reaffirm our fair value range, indicating a favorable risk/reward balance in the share.

Redeye provides an updated view on Genovis following a Q3 report that surpassed our estimates across the board. We have made slight adjustments to our model and largely reaffirm our fair value range, indicating a favorable risk/reward balance in the share.
Börsvärldens nyhetsbrev
ANNONSER